Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-12 08:20 am Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | KOTLER KEVIN | 3,716,242 4.1% | 594,142 (+19.03%) | View |
| 2023-03-09 4:13 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | KOTLER KEVIN | 3,122,100 5.1% | 265,110 (+9.28%) | View |
| 2023-02-13 4:58 pm Sale | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | KOTLER KEVIN | 2,856,990 4.6% | -583,222 (-16.95%) | View |
| 2022-12-20 3:50 pm Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | KOTLER KEVIN | 1,899,930 6.3% | 1,899,930 (New Position) | View |
| 2022-06-06 4:57 pm Purchase | 13G | AVADEL PHARMACEUTICALS PLC SPO AVDL | KOTLER KEVIN | 3,440,212 5.8% | 3,440,212 (New Position) | View |